MedElevator
Войти в исследования Journal of pediatric surgery · 2025
Maternal Plasma Micro-RNAs in Fetal Congenital Diaphragmatic Hernia: A Potential Non-invasive Tool for Prenatal Diagnosis and Risk Stratification.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Liesman Daniel R, Huerta Cassandra B, Papastefan Steven T, Langereis Morgan M, Redden Catherine R, Kang Hee Kap, Ott Katherine C, Turner Lucas, Singh Manmeet, Ito Joyceline A S, Shaaban Aimen F, Alhajjat Amir M
Аннотация
PURPOSE: Congenital diaphragmatic hernia (CDH) is characterized by a wide range of morbidity. Although imaging studies are used for CDH risk stratification, these modalities remain limited in their predictive and informational capacity. Distinct miRNA profiles have been found in other prenatally diagnosed conditions including Twin-Twin Transfusion Syndrome. Furthermore, it is differentially expressed in amniotic fluid from pregnancies with severe CDH suggesting utility in risk stratification. We hypothesized that patients carrying fetuses with CDH would display a unique miRNA profile detectable within maternal plasma that will be associated with both disease and severity.
METHODS: Patients carrying fetuses with CDH (n = 20) and heathy singleton pregnancies (n = 8) were consented for peripheral blood collection. Small RNA sequencing was performed. Subgroup analysis included clinical factors associated with disease severity.
RESULTS: There were 17 differentially expressed miRNAs including several previously implicated in CDH and pulmonary hypertension. Subgroup analysis revealed further differential expression in high-risk CDH patients with distinct clustering of patients with severe and mild disease. 10 miRNAs were associated with clinical severity including let-7c, miR-30 d, and miR-98, miRNAs associated with pulmonary hypertension in the literature. Gene target prediction identified interactions with VEGF and other genes relevant to CDH pathogenesis.
CONCLUSIONS: These results support the hypothesis that maternal plasma miRNA can differentiate pregnancies with CDH from those carrying healthy fetuses. Furthermore, our findings indicate that maternal plasma miRNA can potentially predict severity of disease prenatally. A larger sample size and validation cohort is now prudent.
TYPE OF STUDY: Translational science.
LEVEL OF EVIDENCE: III.
METHODS: Patients carrying fetuses with CDH (n = 20) and heathy singleton pregnancies (n = 8) were consented for peripheral blood collection. Small RNA sequencing was performed. Subgroup analysis included clinical factors associated with disease severity.
RESULTS: There were 17 differentially expressed miRNAs including several previously implicated in CDH and pulmonary hypertension. Subgroup analysis revealed further differential expression in high-risk CDH patients with distinct clustering of patients with severe and mild disease. 10 miRNAs were associated with clinical severity including let-7c, miR-30 d, and miR-98, miRNAs associated with pulmonary hypertension in the literature. Gene target prediction identified interactions with VEGF and other genes relevant to CDH pathogenesis.
CONCLUSIONS: These results support the hypothesis that maternal plasma miRNA can differentiate pregnancies with CDH from those carrying healthy fetuses. Furthermore, our findings indicate that maternal plasma miRNA can potentially predict severity of disease prenatally. A larger sample size and validation cohort is now prudent.
TYPE OF STUDY: Translational science.
LEVEL OF EVIDENCE: III.